Aurobindo Pharma has informed that the officials of the Company will be participating in the investor / analyst meeting with ‘East Bridge Capital’ on July 6, 2023 at 11.00 am in Hyderabad. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The above information is a part of company’s filings submitted to BSE.